Anticoagulants


Anticoagulants are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used to prevent and treat blood clotting disorders. These medications play a crucial role in various medical conditions, including deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF). Anticoagulants work by inhibiting the formation of blood clots or by preventing existing clots from getting larger.

There are different types of anticoagulants available, including direct thrombin inhibitors, vitamin K antagonists, and factor Xa inhibitors. Direct thrombin inhibitors, such as dabigatran, directly target the enzyme thrombin to hinder clot formation. Vitamin K antagonists, like warfarin, interfere with the production of clotting factors that rely on vitamin K. Factor Xa inhibitors, such as rivaroxaban and apixaban, inhibit the activity of factor Xa, a crucial component in the clotting cascade.

Anticoagulants are commonly prescribed to patients at risk of developing blood clots or those with existing clotting disorders. They are often used during surgeries, such as hip or knee replacements, to minimize the risk of post-operative clot formation. Patients with AF, a condition characterized by irregular heart rhythm, may also be prescribed anticoagulants to prevent stroke caused by blood clots.

While anticoagulants offer significant benefits in preventing and treating clot-related conditions, they also carry potential risks, including bleeding complications. Patients taking anticoagulants require careful monitoring to ensure the right dosage is administered, as excessive anticoagulation can lead to hemorrhage. Regular blood tests and close medical supervision are essential to manage the delicate balance between preventing clots and avoiding excessive bleeding.

In conclusion, anticoagulants are a crucial category of pharmaceutical APIs used to prevent and treat blood clotting disorders. They function by inhibiting clot formation or preventing existing clots from enlarging. While highly beneficial, their use requires careful monitoring to minimize the risk of bleeding complications.

NameCAS number
1-Methoxydecane1120-21-4
Abciximab143653-53-6
Acenocoumarol152-72-7
Acetazolamide59-66-5
Aesculin66778-17-4
Apixaban503612-47-3
Argatroban74863-84-6
Astaxanthin472-61-7
Betrixaban330942-05-7
Bivalirudin128270-60-0
Calaspargase pegol941577-06-6
Cangrelor163706-06-7
Carbazochrome sulfonic acid70063-04-6
Cilengitide188968-51-6
Cilostazol73963-72-1
Cinnamic acid140-10-3
Clorindione1146-99-2
Coumarin91-64-5
Dabigatran211914-51-1
Dabigatran etexilate211915-06-9
Dalteparin9005-49-6
Danaparoid308068-55-5
Dermatan sulfate24967-94-0
Diphenadione82-66-6
Dociparstat sodium177021-00-0
Dorzolamide120279-96-1
Edoxaban480449-70-5
Eltrombopag496775-61-2
Enoxaparin9005-49-6
Eptifibatide188627-80-7
Fluindione957-56-2
Fondaparinux sodium114870-03-0
Gabexate39492-01-8
Heparin calcium37270-89-6
Heparin sodium9005-49-6
Heparinoid
Idraparinux162610-17-5
Kappadione131-13-5
Lepirudin138068-37-8
Letaxaban870262-90-1
Menaquinone1182-68-9
Menaquinone 684-81-1
Menaquinone 72124-57-4
Methazolamide554-57-4
Nadroparin9041-08-1
Parnaparin91449-79-5
Phenprocoumon435-97-2
Potassium triiodide12298-68-9
Prasugrel150322-43-3
Protocatechualdehyde139-85-5
Rivaroxaban366789-02-8
Romiplostim267639-76-9
SG31991595275-71-0
Sodium Citrate68-04-2
Streptokinase9002-01-1
Sulodexide57821-29-1
Tenecteplase191588-94-0
Tioclomarol22619-35-8
Tirofiban144494-65-5
Tocopherylquinone7559-04-8
Urokinase9039-53-6
Vorapaxar618385-01-6
Warfarin81-81-2